Hantaan virus can infect human keratinocytes and activate an interferon response through the nuclear translocation of IRF-3

Infection, Genetics and Evolution

Volumn 29, Issue , 2015, Pages 146-155

  Ye, Wei ^a   Xu, Yongni ^a,b   Wang, Yuan ^a   Dong, Yangchao ^a   Xi, Qianqian ^a   Cao, Mengyuan ^a   Yu, Lan ^a   Zhang, Liang ^a   Cheng, Linfeng ^a   Wu, Xingan ^a   Xu, Zhikai ^a   Lei, Yingfeng ^a   Zhang, Fanglin ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Interventional Therapeutic Center   (China)

Author keywords

Hantaan virus; IFN stimulated genes; IFN ; IRF 3; Keratinocyte

Indexed keywords

DEAD-BOX RNA HELICASES; IFIH1 PROTEIN, HUMAN; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; IRF3 PROTEIN, HUMAN; RARRES3 PROTEIN, HUMAN; RECEPTORS, RETINOIC ACID;

CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENETICS; HANTAAN VIRUS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGY; KERATINOCYTES; METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

CELL LINE; CELL NUCLEUS; DEAD-BOX RNA HELICASES; GENE EXPRESSION REGULATION; HANTAAN VIRUS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; KERATINOCYTES; RECEPTORS, RETINOIC ACID; VIRUS REPLICATION;

EID: 84914166662     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.11.009     Document Type: Article

References (86)

1. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
2. Aksoy P., Abban C.Y., Kiyashka E., Qiang W., Meneses P.I. HPV16 infection of HaCaTs is dependent on beta4 integrin, and alpha6 integrin processing. Virology 2014, 449:45-52.
3. Alff P.J., Sen N., Gorbunova E., Gavrilovskaya I.N., Mackow E.R. The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation. J. Virol. 2008, 82:9115-9122.
4. Andrejeva J., Norsted H., Habjan M., Thiel V., Goodbourn S., Randall R.E. ISG56/IFIT1 is primarily responsible for interferon-induced changes to patterns of parainfluenza virus type 5 transcription and protein synthesis. J. Gen. Virol. 2013, 94:59-68.
5. Au-Yeung N., Mandhana R., Horvath C.M. Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway. JAKSTAT 2013, 2:e23931.
6. Bourne N., Scholle F., Silva M.C., Rossi S.L., Dewsbury N., Judy B., De Aguiar J.B., Leon M.A., Estes D.M., Fayzulin R., Mason P.W. Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production. J. Virol. 2007, 81:9100-9108.
7. Brownell J., Bruckner J., Wagoner J., Thomas E., Loo Y.M., Gale M., Liang T.J., Polyak S.J. Direct, interferon-independent activation of the CXCL10 promoter by NF-kappaB and interferon regulatory factor 3 during hepatitis C virus infection. J. Virol. 2014, 88:1582-1590.
8. Bustos-Arriaga J., Garcia-Machorro J., Leon-Juarez M., Garcia-Cordero J., Santos-Argumedo L., Flores-Romo L., Mendez-Cruz A.R., Juarez-Delgado F.J., Cedillo-Barron L. Activation of the innate immune response against DENV in normal non-transformed human fibroblasts. PLoS Negl. Trop. Dis. 2011, 5:e1420.
9. Cheng L., Yu L., Wu X., Li K., Wang F., Zhang L., Ye W., Li P., Zhang F., Xu Z. Induction of specific humoral and cellular immune responses in a mouse model following gene fusion of HSP70C and Hantaan virus Gn and S0.7 in an adenoviral vector. PLoS ONE 2014, 9:e88183.
10. Childs K., Stock N., Ross C., Andrejeva J., Hilton L., Skinner M., Randall R., Goodbourn S. Mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 2007, 359:190-200.
11. Daffis S., Szretter K.J., Schriewer J., Li J., Youn S., Errett J., Lin T.Y., Schneller S., Zust R., Dong H., Thiel V., Sen G.C., Fensterl V., Klimstra W.B., Pierson T.C., Buller R.M., Gale M., Shi P.Y., Diamond M.S. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 2010, 468:452-456.
12. Deng J.X., Nie X.J., Lei Y.F., Ma C.F., Xu D.L., Li B., Xu Z.K., Zhang G.C. The highly conserved 5' untranslated region as an effective target towards the inhibition of Enterovirus 71 replication by unmodified and appropriate 2'-modified siRNAs. J. Biomed. Sci. 2012, 19:73.
13. Diamond M.S., Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 2013, 13:46-57.
14. Easterbrook J.D., Klein S.L. Immunological mechanisms mediating Hantavirus persistence in rodent reservoirs. PLoS Pathog. 2008, 4:e1000172.
15. Fensterl V., Sen G.C. The ISG56/IFIT1 gene family. J. Interferon Cytokine Res. 2011, 31:71-78.
16. Fitzgerald K.A., Rowe D.C., Barnes B.J., Caffrey D.R., Visintin A., Latz E., Monks B., Pitha P.M., Golenbock D.T. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med. 2003, 198:1043-1055.
17. Frese M., Kochs G., Feldmann H., Hertkorn C., Haller O. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J. Virol. 1996, 70:915-923.
18. Guhl S., Franke R., Schielke A., Johne R., Kruger D.H., Babina M., Rang A. Infection of in vivo differentiated human mast cells with hantaviruses. J. Gen. Virol. 2010, 91:1256-1261.
19. Habjan M., Andersson I., Klingstrom J., Schumann M., Martin A., Zimmermann P., Wagner V., Pichlmair A., Schneider U., Muhlberger E., Mirazimi A., Weber F. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 2008, 3:e2032.
20. Hacker H., Tseng P.H., Karin M. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat. Rev. Immunol. 2011, 11:457-468.
21. Handke W., Oelschlegel R., Franke R., Kruger D.H., Rang A. Hantaan virus triggers TLR3-dependent innate immune responses. J. Immunol. 2009, 182:2849-2858.
22. Hardestam J., Karlsson M., Falk K.I., Olsson G., Klingstrom J., Lundkvist A. Puumala hantavirus excretion kinetics in bank voles (Myodes glareolus). Emerg. Infect. Dis. 2008, 14:1209-1215.
23. Havell E.A., Berman B., Ogburn C.A., Berg K., Paucker K., Vilcek J. Two antigenically distinct species of human interferon. Proc. Natl. Acad. Sci. U.S.A. 1975, 72:2185-2187.
24. Hepojoki J., Strandin T., Lankinen H., Vaheri A. Hantavirus structure-molecular interactions behind the scene. J. Gen. Virol. 2012, 93:1631-1644.
25. Hiscott J. Triggering the Innate Antiviral Response through IRF-3 Activation. J. Biol. Chem. 2007, 282:15325-15329.
26. Hoover L.I., Fredericksen B.L. IFN-dependent and -independent reduction in West Nile virus infectivity in human dermal fibroblasts. Viruses 2014, 6:1424-1441.
27. Hou F., Sun L., Zheng H., Skaug B., Jiang Q.X., Chen Z.J. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146:448-461.
28. Houck M.A., Qin H., Roberts H.R. Hantavirus transmission: potential role of ectoparasites. Vector Borne Zoonotic Dis. 2001, 1:75-79.
29. Jiang X., Kinch L.N., Brautigam C.A., Chen X., Du F., Grishin N.V., Chen Z.J. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 2012, 36:959-973.
30. Jonsson C.B., Figueiredo L.T., Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin. Microbiol. Rev. 2010, 23:412-441.
31. Kalali B.N., Kollisch G., Mages J., Muller T., Bauer S., Wagner H., Ring J., Lang R., Mempel M., Ollert M. Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling. J. Immunol. 2008, 181:2694-2704.
32. Kallio E.R., Begon M., Henttonen H., Koskela E., Mappes T., Vaheri A., Vapalahti O. Cyclic hantavirus epidemics in humans-predicted by rodent host dynamics. Epidemics 2009, 1:101-107.
33. Kanerva M., Melen K., Vaheri A., Julkunen I. Inhibition of puumala and tula hantaviruses in Vero cells by MxA protein. Virology 1996, 224:55-62.
34. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 2005, 6:981-988.
35. Kim I.W., Hwang J.Y., Kim S.K., Kim J.K., Park H.S. Interferon-stimulated genes response in endothelial cells following Hantaan virus infection. J. Korean Med. Sci. 2007, 22:987-992.
36. Kimura T., Katoh H., Kayama H., Saiga H., Okuyama M., Okamoto T., Umemoto E., Matsuura Y., Yamamoto M., Takeda K. Ifit1 inhibits Japanese encephalitis virus replication through binding to 5' capped 2'-O unmethylated RNA. J. Virol. 2013, 87:9997-10003.
37. Kolakofsky D., Kowalinski E., Cusack S. A structure-based model of RIG-I activation. RNA 2012, 18:2118-2127.
38. Labuda M. Arthropod vectors in the evolution of bunyaviruses. Acta Virol. 1991, 35:98-105.
39. Lee M.H., Lalwani P., Raftery M.J., Matthaei M., Lutteke N., Kirsanovs S., Binder M., Ulrich R.G., Giese T., Wolff T., Kruger D.H., Schonrich G. RNA helicase retinoic acid-inducible gene I as a sensor of Hantaan virus replication. J. Gen. Virol. 2011, 92:2191-2200.
40. Li J., Liu K., Liu Y., Xu Y., Zhang F., Yang H., Liu J., Pan T., Chen J., Wu M., Zhou X., Yuan Z. Exosomes mediate the cell-to-cell transmission of IFN-alpha-induced antiviral activity. Nat. Immunol. 2013, 14:793-803.
41. Lim P.Y., Behr M.J., Chadwick C.M., Shi P.Y., Bernard K.A. Keratinocytes are cell targets of West Nile virus in vivo. J. Virol. 2011, 85:5197-5201.
42. Lupfer C., Kanneganti T.D. The expanding role of NLRs in antiviral immunity. Immunol. Rev. 2013, 255:13-24.
43. Maas-Szabowski N., Szabowski A., Stark H.J., Andrecht S., Kolbus A., Schorpp-Kistner M., Angel P., Fusenig N.E. Organotypic cocultures with genetically modified mouse fibroblasts as a tool to dissect molecular mechanisms regulating keratinocyte growth and differentiation. J. Invest. Dermatol. 2001, 116:816-820.
44. Mackow E.R., Dalrymple N.A., Cimica V., Matthys V., Gorbunova E., Gavrilovskaya I. Hantavirus interferon regulation and virulence determinants. Virus Res 2014.
45. Manigold T., Vial P. Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology. Swiss Med. Wkly. 2014, 144:w13937.
46. Markotic A., Hensley L., Daddario K., Spik K., Anderson K., Schmaljohn C. Pathogenic hantaviruses elicit different immunoreactions in THP-1 cells and primary monocytes and induce differentiation of human monocytes to dendritic-like cells. Coll. Antropol. 2007, 31:1159-1167.
47. Marsac D., Garcia S., Fournet A., Aguirre A., Pino K., Ferres M., Kalergis A.M., Lopez-Lastra M., Veas F. Infection of human monocyte-derived dendritic cells by ANDES Hantavirus enhances pro-inflammatory state, the secretion of active MMP-9 and indirectly enhances endothelial permeability. Virol. J. 2011, 8:223.
48. Martinez V.P., Bellomo C., San Juan J., Pinna D., Forlenza R., Elder M., Padula P.J. Person-to-person transmission of Andes virus. Emerg. Infect. Dis. 2005, 11:1848-1853.
49. Matthys V., Mackow E.R. Hantavirus regulation of type I interferon responses. Adv. Virol. 2012, 2012:524024.
50. Matthys V., Gorbunova E.E., Gavrilovskaya I.N., Pepini T., Mackow E.R. The C-terminal 42 residues of the Tula virus Gn protein regulate interferon induction. J. Virol. 2011, 85:4752-4760.
51. Matthys V.S., Cimica V., Dalrymple N.A., Glennon N.B., Bianco C., Mackow E.R. Hantavirus GnT elements mediate TRAF3 binding and inhibit RIG-I/TBK1-directed beta interferon transcription by blocking IRF3 phosphorylation. J. Virol. 2014, 88:2246-2259.
52. Mesic S., Almedin H. [Investigation of modes of hantavirus infection transmission from rodents to humans]. Med. Arh. 2008, 62:229-230.
53. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437:1167-1172.
54. Mustonen J., Makela S., Outinen T., Laine O., Jylhava J., Arstila P.T., Hurme M., Vaheri A. The pathogenesis of nephropathia epidemica: new knowledge and unanswered questions. Antivir. Res 2013.
55. Nestle F.O., Di Meglio P., Qin J.Z., Nickoloff B.J. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 2009, 9:679-691.
56. Oganesyan G., Saha S.K., Guo B., He J.Q., Shahangian A., Zarnegar B., Perry A., Cheng G. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2006, 439:208-211.
57. Pedrosa P.B., Cardoso T.A. Viral infections in workers in hospital and research laboratory settings: a comparative review of infection modes and respective biosafety aspects. Int J Infect Dis 2011, 15:e366-376.
58. Pichlmair A., Lassnig C., Eberle C.A., Gorna M.W., Baumann C.L., Burkard T.R., Burckstummer T., Stefanovic A., Krieger S., Bennett K.L., Rulicke T., Weber F., Colinge J., Muller M., Superti-Furga G. IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat. Immunol. 2011, 12:624-630.
59. Prescott J., Ye C., Sen G., Hjelle B. Induction of innate immune response genes by Sin Nombre hantavirus does not require viral replication. J. Virol. 2005, 79:15007-15015.
60. Prescott J.B., Hall P.R., Bondu-Hawkins V.S., Ye C., Hjelle B. Early innate immune responses to Sin Nombre hantavirus occur independently of IFN regulatory factor 3, characterized pattern recognition receptors, and viral entry. J. Immunol. 2007, 179:1796-1802.
61. Puiprom O., Morales Vargas R.E., Potiwat R., Chaichana P., Ikuta K., Ramasoota P., Okabayashi T. Characterization of chikungunya virus infection of a human keratinocyte cell line: role of mosquito salivary gland protein in suppressing the host immune response. Infect. Genet. Evol. 2013, 17:210-215.
62. Raftery M.J., Kraus A.A., Ulrich R., Kruger D.H., Schonrich G. Hantavirus infection of dendritic cells. J. Virol. 2002, 76:10724-10733.
63. Rang A. Modulation of innate immune responses by hantaviruses. Crit. Rev. Immunol. 2010, 30:515-527.
64. Sato S., Sugiyama M., Yamamoto M., Watanabe Y., Kawai T., Takeda K., Akira S. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 2003, 171:4304-4310.
65. Schlee M. Master sensors of pathogenic RNA - RIG-I like receptors. Immunobiology 2013, 218:1322-1335.
66. Schneider W.M., Chevillotte M.D., Rice C.M. Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 2014, 32:513-545.
67. Schountz T., Prescott J. Hantavirus immunology of rodent reservoirs: current status and future directions. Viruses 2014, 6:1317-1335.
68. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 2001, 55:255-281.
69. Seth R.B., Sun L., Ea C.K., Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122:669-682.
70. Sinisalo M., Vapalahti O., Ekblom-Kullberg S., Laine O., Makela S., Rintala H., Vaheri A. Headache and low platelets in a patient with acute leukemia. J. Clin. Virol. 2010, 48:159-161.
71. Spiropoulou C.F., Albarino C.G., Ksiazek T.G., Rollin P.E. Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J. Virol. 2007, 81:2769-2776.
72. Surasombatpattana P., Hamel R., Patramool S., Luplertlop N., Thomas F., Desprès P., Briant L., Yssel H., Missé D. Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses. Infect. Genet. Evol. 2011, 11:1664-1673.
73. Temonen M., Lankinen H., Vapalahti O., Ronni T., Julkunen I., Vaheri A. Effect of interferon-alpha and cell differentiation on Puumala virus infection in human monocyte/macrophages. Virology 1995, 206:8-15.
74. Vaheri A., Strandin T., Hepojoki J., Sironen T., Henttonen H., Makela S., Mustonen J. Uncovering the mysteries of hantavirus infections. Nat. Rev. Microbiol. 2013, 11:539-550.
75. Wang H., Vaheri A., Weber F., Plyusnin A. Old World hantaviruses do not produce detectable amounts of dsRNA in infected cells and the 5' termini of their genomic RNAs are monophosphorylated. J. Gen. Virol. 2011, 92:1199-1204.
76. Wesley C.L., Allen L.J., Langlais M. Models for the spread and persistence of hantavirus infection in rodents with direct and indirect transmission. Math. Biosci. Eng. 2010, 7:195-211.
77. Wojcik-Fatla A., Zajac V., Knap J.P., Dutkiewicz J. Hantavirus RNA not detected in Ixodes ricinus ticks. Ann. Agric. Environ. Med. 2011, 18:446-447.
78. Wojcik-Fatla A., Zajac V., Knap J.P., Dutkiewicz J. Hantavirus RNA was not detected in Dermacentor reticulatus ticks. Ann. Agric. Environ. Med. 2013, 20:452-454.
79. Xu Z.Y., Guo C.S., Wu Y.L., Zhang X.W., Liu K. Epidemiological studies of hemorrhagic fever with renal syndrome: analysis of risk factors and mode of transmission. J. Infect. Dis. 1985, 152:137-144.
80. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z., Shu H.B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 2005, 19:727-740.
81. Yan N., Chen Z.J. Intrinsic antiviral immunity. Nat. Immunol. 2012, 13:214-222.
82. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5:730-737.
83. Yu H.T., Jiang H., Zhang Y., Nan X.P., Li Y., Wang W., Jiang W., Yang D.Q., Su W.J., Wang J.P., Wang P.Z., Bai X.F. Hantaan virus triggers TLR4-dependent innate immune responses. Viral Immunol. 2012, 25:387-393.
84. Zaki S.R., Greer P.W., Coffield L.M., Goldsmith C.S., Nolte K.B., Foucar K., Feddersen R.M., Zumwalt R.E., Miller G.L., Khan A.S., et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol. 1995, 146:552-579.
85. Zhang Y.Z. Discovery of hantaviruses in bats and insectivores and the evolution of the genus Hantavirus. Virus Res 2014.
86. Zhang Y., Liu B., Ma Y., Yi J., Zhang C., Zhang Y., Xu Z., Wang J., Yang K., Yang A., Zhuang R., Jin B. Hantaan virus infection induces CXCL10 Expression through TLR3, RIG-I, and MDA-5 Pathways Correlated with the Disease Severity. Mediat. Inflamm. 2014, 2014:11.